NYSEAMERICAN:NSPR - InspireMD Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.49 -0.36 (-7.42 %) (As of 04/19/2019 04:00 PM ET)Previous Close$4.49Today's Range$4.49 - $4.9552-Week Range$4.01 - $82.00Volume141,244 shsAverage Volume84,009 shsMarket Capitalization$6.10 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel. Receive NSPR News and Ratings via Email Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:NSPR Previous SymbolNASDAQ:NSPR CUSIPN/A CIK1433607 Webwww.inspiremd.com Phone+1-857-4536553Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees43 Outstanding Shares1,358,000Market Cap$6.10 million Next Earnings Date5/6/2019 (Estimated) OptionableNot Optionable InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions What is InspireMD's stock symbol? InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR." When did InspireMD's stock split? How did InspireMD's stock split work? InspireMD's stock reverse split before market open on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split. How were InspireMD's earnings last quarter? InspireMD Inc (NYSEAMERICAN:NSPR) posted its earnings results on Tuesday, February, 19th. The medical equipment provider reported ($2.50) earnings per share for the quarter. The medical equipment provider earned $0.82 million during the quarter. View InspireMD's Earnings History. When is InspireMD's next earnings date? InspireMD is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for InspireMD. What is the consensus analysts' recommendation for InspireMD? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD. Has InspireMD been receiving favorable news coverage? Media stories about NSPR stock have been trending positive this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. InspireMD earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the stock's share price in the near future. Are investors shorting InspireMD? InspireMD saw a decline in short interest in March. As of March 29th, there was short interest totalling 585,759 shares, a decline of 13.2% from the March 15th total of 675,094 shares. Based on an average daily trading volume, of 1,313,324 shares, the days-to-cover ratio is presently 0.4 days. Approximately 79.0% of the shares of the company are sold short. View InspireMD's Current Options Chain. Who are some of InspireMD's key competitors? Some companies that are related to InspireMD include LiDCO Group (LID), Intelligent Ultrasound Group (MED), Zecotek Photonics (ZMS), Deltex Medical Group (DEMG), Bioquell (BQE), Lucid (LCDX) and Verisante Technology (VRS). What other stocks do shareholders of InspireMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Curis (CRIS), Inovio Pharmaceuticals (INO), Novavax (NVAX), Vascular Biogenics (VBLT), Atossa Genetics (ATOS), AVEO Pharmaceuticals (AVEO) and Biocept (BIOC). Who are InspireMD's key executives? InspireMD's management team includes the folowing people: Dr. James J. Barry, Pres, CEO & Director (Age 60)Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)Mr. Benzi Spector, Head of R&D and OperationsDr. Sol J. Barer, Special Advisor to the Board (Age 72) How do I buy shares of InspireMD? Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is InspireMD's stock price today? One share of NSPR stock can currently be purchased for approximately $4.49. How big of a company is InspireMD? InspireMD has a market capitalization of $6.10 million. InspireMD employs 43 workers across the globe. What is InspireMD's official website? The official website for InspireMD is http://www.inspiremd.com/. How can I contact InspireMD? InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553. MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 140 (Vote Outperform)Underperform Votes: 131 (Vote Underperform)Total Votes: 271MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/20/2019 by MarketBeat.com StaffFeatured Article: What are the benefits of momentum investing?